Greenlane (GNLN) director gets 315,000 options, 15,000 shares

Greenlane Holdings (GNLN) reported an insider equity grant.

Rhea-AI Filing Summary

Greenlane Holdings (GNLN) reported an insider equity grant. A director acquired 15,000 shares of Class A Common Stock on 10/20/2025 at a reported price of $0.00, noted as restricted stock issued under the 2019 Equity Incentive Plan. The filing also reports a grant of stock options for 315,000 shares of Class A Common Stock at an exercise price of $3.84.

The options vest in full upon grant and carry an expiration date of 10/20/2030. Following the transactions, the director reports 15,000 shares directly owned and 315,000 options directly held. The option allocation is described as part of the Company’s 3,000,000-share ESOP distribution approved by the Board on October 14, 2025.

Insider Trade Summary

Grant/Award: 330,000 shares

Grant/Award 2 txns

Insider Persofsky Renah

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	315,000	$0.001	$315.00
Grant/Award	Class A Common Stock	15,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 315,000 contracts (Direct); Class A Common Stock — 15,000 shares (Direct)

Footnotes (4)

1. F1. Represents shares of restricted stock issued as compensatory equity under the Company's 2019 Equity Incentive Plan.
2. F2. The exercise price equals the closing price of Greenlane Holdings, Inc. Class A Common Stock on October 17, 2025.
3. F3. Options vest in full upon grant in consideration of executive service and expire five (5) years from the grant date, unless earlier terminate dunder Plan terms.
4. F4. The option allocation is from the Company's 3,000,000 share ESOP distribution approved and ratified by the Board on October 14, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GNLN disclose on this Form 4?

A director received 15,000 restricted shares at $0.00 and stock options for 315,000 shares at an exercise price of $3.84 on 10/20/2025.

What is the exercise price and term of the new GNLN options?

The options have an exercise price of $3.84 and expire on 10/20/2030.

When do the GNLN options vest?

They vest in full upon grant, according to the filing’s explanation.

How many GNLN shares and options does the insider hold after the transactions?

The insider directly holds 15,000 shares and 315,000 stock options.

What plan governed the restricted stock grant at GNLN?

The 2019 Equity Incentive Plan governed the restricted stock issuance.

What is the source of the option allocation at GNLN?

It comes from the Company’s 3,000,000-share ESOP distribution approved by the Board on October 14, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/23/2025 - 09:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Persofsky Renah

(Last) (First) (Middle)

4800 N FEDERAL HWY, SUITE B200

(Street)

BOCA RATON FL 33431

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Greenlane Holdings, Inc. [ GNLN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/20/2025		A		15,000	A	$0.00(1)	15,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$3.84(2)	10/20/2025		A		315,000(4)		(3)	10/20/2030	Class A Common Stock	315,000	$0.001	315,000	D

Explanation of Responses:

1. Represents shares of restricted stock issued as compensatory equity under the Company's 2019 Equity Incentive Plan.

2. The exercise price equals the closing price of Greenlane Holdings, Inc. Class A Common Stock on October 17, 2025.

3. Options vest in full upon grant in consideration of executive service and expire five (5) years from the grant date, unless earlier terminate dunder Plan terms.

4. The option allocation is from the Company's 3,000,000 share ESOP distribution approved and ratified by the Board on October 14, 2025.

	/s/ Renah Perofsky	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.